Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2011-04-12
Original SEC Filing: Click here

---

Webplus: BSPM/20110412/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
BioStar Pharmaceuticals Announces Appointment of New Chief Financial Officer; Appoints Auditmmittee Chairman and Independent Director to the Board of Directors Finally, thempanyso announced that the Board has appointed Mr. King-fai (Patrick) Leung an independent director to the Board and Chairman of theAuditmmittee to fill vacancies resulting from Mr. Pans departures, discussedove.

---

---

Webplus: BSPM/20110412/8-K/1/000.htm SEC Original: biostarpharma8k041211.htm
______________ FORM 8-K ______________ CURRENT REPORTte of Report (Date of earliest event reported):April 6, 2011 ______________ BIOSTAR PHARMACEUTICALS, ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Avenue Xianyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 N/A (Former name or formerdress, if changed since last

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2011-04-12CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046